Union Government has decided to support some public sector companies with grants under the Mission COVID Suraksha to boost covid-19 vaccine production. Among the companies, one is Hyderabad based Indian Immunological limited (IIL), a facility under PSU named “National Dairy Development Board”. IIL and Bharat Biotech have signed a technical agreement for IIL to supply drug substance to Bharat Biotech, required to produce COVAXIN Vaccine.
Mission COVID Suraksha :- Mission COVID Suraksha was launched under Atmanirbhar Bharat 3.0 and is targeted effort which enable development of indigenous, affordable and accessible vaccines in India. Mission focuses on preclinical development through clinical trials and manufacturing & regulatory facilitation to consolidate all available and funded resources to accelerate development of product. Phase-I of COVID Suraksha Mission was allotted rs 900 Crore for 12 months. Grant was provided by department of biotechnology (DBT) to conduct Research and Development on Indian Covid-19 vaccines. COVID Mission is led by DBT while a “Mission Implementation Unit” at Biotechnology Industry Research Assistance Council (BIRAC) implemented it.